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Abstract
Objective—To investigate the role of obesity-associated inflammation and immune modulation
in gastric carcinogenesis during Helicobacter-induced chronic gastric inflammation.
Design—C57BL/6 male mice were infected with H felis and placed on a high-fat diet (45%
calories from fat). Study animals were analysed for gastric and adipose pathology, inflammatory
markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach
and adipose tissue.
Results—H felis-induced gastric carcinogenesis was accelerated in diet-induced obese mice
compared with lean controls. Obesity increased bone marrow-derived immature myeloid cells in
blood and gastric tissue of H felis-infected mice. Obesity also led to elevations in CD4 T cells,
IL-17A, granulocyte macrophage colony-stimulating factor, phosphorylated STAT3 and
prosurvival gene expression in gastric tissue of H felis-infected mice. Conversely, in adipose tissue
of obese mice, H felis infection increased macrophage accumulation and expression of IL-6, C-C
motif ligand 7 (CCL7) and leptin. Finally, the combination of obesity and gastric inflammation
synergistically increased serum proinflammatory cytokines, including IL-6.
Conclusions—Here, we have established a model to study the molecular mechanism by which
obesity predisposes individuals to gastric cancer. In H felis-infected mice, obesity increased
proinflammatory immune responses and accelerated gastric carcinogenesis. Interestingly, gastric
inflammation augmented obesity-induced adipose inflammation and production of adipose-
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derived factors in obese, but not lean, mice. Our findings suggest that obesity accelerates
Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed
gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby
contributing to a protumorigenic gastric microenvironment.
INTRODUCTION
Gastric cancer is the fourth most common cancer and the second leading cause of cancer-
related death worldwide.1Helicobacter pylori, a bacterium that infects humans and colonises
the stomach, causing chronic gastritis and gastric cancer.2–4 Among all individuals infected
with H pylori, approximately 1–3% progress to gastric cancer.1 As nearly half the world's
population is infected, H pylori contributes significantly to the global gastric cancer burden.1
Obese individuals not only have a greater risk of certain cancers, including gastric cancer,
but also suffer from higher cancer mortality rates.5 The incidence of obesity and obesity-
associated diseases are rising at an alarming rate worldwide.67 Research on these diseases,
including type II diabetes and atherosclerosis, highlights obesity-induced inflammation as a
common underlying feature.6–9 Studies in mice have shown that obesity can promote
multiple cancers (including colorectal and pancreatic cancer) and implicates systemic
inflammation in this process.1011 Research in this field has largely focused on the direct
effect of adipose-derived factors on established tumours. However, little is known about the
effect of obesity on immune modulation, the establishment of a protumorigenic
microenvironment and cancer initiation.7
To investigate the effects of obesity on gastric inflammation and carcinogenesis, we placed
Helicobacter felis-infected mice on a high-fat diet (HFD, 45% calories from fat). Chronic
administration of a HFD is a clinically relevant model of obesity.12 Mice exposed to this diet
develop a metabolic phenotype similar to that observed in obese humans, characterised by
adipose inflammation, hyperglycaemia and insulin resistance.913H felis infection is
commonly used as a murine model of gastric cancer, as H felis infection in mice
recapitulates the pathological progression from gastritis to dysplasia to cancer observed in
chronic human H pylori infection.14
Helicobacter-dependent gastric cancer in mice and humans is associated with a sustained
gastric immune response that involves cells of both lymphoid and myeloid origin. The
circulating and gastric populations of CD11bGr1 immature myeloid cells (IMCs) increase
early in the disease process, and have been implicated in cancer initiation.15 IMCs are a
heterogeneous cell population and include myeloid-derived suppressor cells (MDSCs),
among other cell populations.16 MDSCs are characterised by their ability to suppress
cytotoxic CD8 T cell activation, preventing antitumour immunity and promoting the
survival of transformed epithelial cells.16–20 Cytokines and growth factors, including
interleukin (IL)-6 and granulocyte macrophage-colony stimulating factor (GM-CSF), have
been shown to play an important role in MDSC recruitment and activity.16 17 In addition to
IMC involvement, Helicobacter-driven carcinogenesis is also associated with increased T
helper 1 (TH1) and TH17 immune responses.2122 The role of TH17 cells, and the
prototypical TH17 cytokine IL-17A,23 in tumour development remains controversial and is
likely dependent on tissue type, tumour stage and microenvironment.2425 Nevertheless, a
heightened TH17 response has been positively correlated with more advanced gastric
pathology,26 and attenuation of the TH17 response has been associated with reduced gastric
dysplasia.27
As in gastric cancer, proinflammatory immune responses are also initiated during obesity.6
During obesity, adipose tissue undergoes substantial tissue remodelling as adipocytes
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become hypertrophic and hyperplastic, causing increased adipose tissue inflammation.6
Accumulation of adipose tissue macrophages has been identified as one of the main sources
of this adipose inflammation.68 Communication between macrophages and adipocytes
enhances cytokine production, including tumour necrosis factor (TNF)-α, IL-6 and IL-1β,
which furthers macrophage recruitment, and perpetuates the inflammatory response.8
Adipose-derived factors, specifically TNF-α, IL-6, plasminogen activator inhibitor-1
(PAI-1) and leptin, have been proposed to increase susceptibility to multiple cancers during
obesity, but the specific mechanisms are not well understood.12 Activation of signal
transducer and activator of transcription 3 (STAT3), a known oncoprotein by IL-6 and
leptin, has been proposed as one key mechanism involved in obesity-associated cancer
risk.12 Additionally, high leptin levels have been shown to promote proinflammatory Tcells
while suppressing regulatory Tcells.28
The aim of this study was to investigate the effect of diet-induced obesity on Helicobacter-
associated gastric inflammation and carcinogenesis. We hypothesised that obesity-induced
inflammation and immune activation in adipose tissue would amplify tumorigenic gastric
inflammation. We also sought to better define the interaction between immune responses
initiated by obesity and gastric helicobacter infection. Our data demonstrate that obesity-
associated adipose inflammation enhanced gastric inflammation during H felis infection and
accelerated gastric preneoplasia.
MATERIALS AND METHODS
Male C57BL/6 mice were infected with H felis at 8 weeks as previously described.29
Infected and uninfected mice were fed either a HFD (45% of calories from fat, Research
Diets 12451) or a standard chow diet (CD, 13% of calories from fat, PicoLab Rodent Diet
20) ad libitum. HFD was begun 3 weeks postinfection (PI). Methods for metabolic profile
assays, immunohistochemistry (IHC), protein quantification, real-time qRT-PCR,
chemokine infusion studies, BrdU injection, flow cytometry, in vitro T cell differentiation
and transwell migration assays are provided in the online supplement.
RESULTS
Diet-induced obesity accelerates H felis-induced carcinogenesis
To determine if obesity can augment H felis-driven carcinogenesis, infected mice were fed a
HFD (45% calories from fat) or standard CD (13% calories from fat) from 3 weeks PI until
euthanasia at 10 and 15 months PI. Uninfected control mice were placed on the same
feeding regimen. Hereafter, we will refer to these four study groups as: H felis/HFD, H felis/
CD, uninfected/HFD and uninfected/CD. As expected, mice on HFD gained significantly
more weight than mice on CD (figure 1A). H felis infection did not alter weight gain, body
composition, or fasting glucose and insulin levels compared with controls (figure 1A, see
online supplementary figure S1A,B, data not shown). Diet did not alter H felis colonisation
density (data not shown).
H felis infection resulted in gastric dysplasia in all animals. Gross gastric lesions in H felis/
HFD mice were roughly twice the size of those in H felis/CD mice at 15 months PI (figure
1B, C). In infected mice, obesity significantly increased severity of inflammation, epithelial
defects, metaplasia and dysplasia at both time points (figure 1D,E). HFD alone did not
induce gastric inflammation or dysplasia (figure 1C–E).
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Adipose-derived factors activate STAT3 in gastric tissue
Sustained STAT3 signalling in epithelial cells has been shown to promote cell survival and
proliferation in multiple cancer models, including gastric cancer.2530 Accordingly, we
analysed gastric corpus tissue for activated, phosphorylated STAT3 (pSTAT3) by IHC. At
15 months PI, H felis/HFD mice had widespread pSTAT3 staining in epithelial and stromal
cells compared with controls. H felis infection alone resulted in moderate stromal and
minimal epithelial STAT3 activation. By contrast, H felis plus HFD resulted in widespread
stromal and epithelial STAT3 activation, suggesting that HFD may contribute to gastric
epithelial cell survival during chronic H felis infection. pSTAT3 staining was extremely rare
in uninfected mice (figure 1F). STAT3 can exert oncogenic effects in epithelial cells through
upregulation of prosurvival/antiapoptotic genes, including survivin, Bcl-XL, Mcl1 and c-
Myc,30 and by driving expression of certain microRNAs, such as miR21 and miR181b1.31
Expression of these STAT3 target genes and microRNAs were significantly upregulated in
gastric tissues of H felis/HFD mice compared with H felis/CD mice (figure 1G). To identify
possible initiators of the observed gastric STAT3 activity, we assessed factors known to
initiate STAT3 phosphorylation and nuclear translocation, including IL-6, IL-11 and
leptin.530 Interestingly, HFD did not increase expression of IL-6 or IL-11 in gastric corpus
tissue of infected mice (see online supplementary figure S1C). It is possible that these
factors were upregulated in other tissues, such as adipose tissue, and travelled to the stomach
to activate STAT3, therefore, we measured IL-6 and leptin concentrations in the serum. We
detected increased serum concentration of IL-6 and leptin in H felis/HFD mice, compared
with H felis/CD mice (figure 1H). These data suggest that obesity and H felis infection
synergistically increased serum IL-6 and leptin levels, likely enhancing STAT3-mediated
gastric epithelial transformation beyond that observed with H felis infection alone.
Obesity enhances IMC trafficking
During obesity, bone marrow-derived IMCs traffic to adipose tissue, but it is unknown if
these populations interact or overlap with IMCs implicated in gastric tumorigenesis.32 Using
flow cytometry, we quantified CD11bGR1 IMC subpopulations in the stomach, blood and
spleen, using the cell surface markers F4/80, Ly6C and Ly6G (for gating strategy, see online
supplementary figure S2A). CD11bGR1 IMCs were significantly elevated in gastric and
splenic tissues of all infected mice, and in the blood of all mice on HFD (figure 2A). In
gastric tissue and blood, F4/80lowLy6G IMCs were significantly elevated in H felis/HFD
mice compared with H felis/CD mice, indicating that this neutrophil-like IMC subset4 is
most sensitive to a HFD in the context of H felis infection (figure 2B). Additional IMC
populations were modulated by H felis or HFD status, though blood or spleen concentrations
did not correlate with gastric levels (see online supplementary figure S2B).
MDSCs, a subset of CD11bGR1 IMCs, can curb proliferation of cytotoxic CD8 T cells and
dampen antitumour immunity, partially through the production of arginase 1 (Arg1) and
inducible nitric oxide synthase (iNOS).3 A trend toward increased gastric Arg1 and iNOS
expression was observed in H felis/HFD mice compared with H felis/CD mice, suggesting
that IMCs recruited to the stomach of H felis/HFD mice exhibit immunosuppressive activity
(figure 2C). Collectively, these data indicate that obesity may accelerate H felis-dependent
carcinogenesis by increasing MDSC accumulation in the stomach.
To identify chemokines involved in IMC recruitment, we measured serum levels of
chemokine C-X-C motif ligand (CXCL)- 1, 2, 5 and C-C motif ligand (CCL)- 2, 3, 4. Of
these, CXCL1 was the only chemokine significantly elevated in serum of H felis/HFD mice
compared with all control groups (figure 2D, data not shown). This finding is consistent
with data reporting a role for CXCL1 in the recruitment of neutrophil-like IMCs.3334 To
identify the possible sources of serum CXCL1, we quantified adipose and gastric CXCL1
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mRNA. In adipose tissue, CXCL1 expression was increased almost sixfold in H felis/HFD
compared with H felis/CD. In gastric tissue, CXCL1 expression was increased threefold in H
felis/HFD compared with H felis/CD mice. We observed no synergistic upregulation of
CXCL1 in adipose or gastric tissue of H felis/HFD mice (figure 2E). Thus, it appears that
HFD and H felis infection independently upregulate CXCL1 expression in the adipose tissue
and stomach, respectively. The elevated serum CXCL1 protein observed in H felis/HFD
mice is likely a result of increased CXCL1 secretion from both gastric and adipose tissues,
although adipose tissue may be a larger contributor. To test if CXCL1 can directly affect
F4/80lowLy6G IMC mobilisation, we performed a transwell migration assay using
CD11bGr1 IMCs isolated from bone marrow of uninfected lean mice. Indeed, CXCL1
caused a potent and dose-dependent migratory response of F4/80lowLy6G IMCs (figure 2F).
To demonstrate the specificity of the migration assay, we applied F4/80intLy6C IMCs to the
transwell, and confirmed that this monocyte-like subpopulation did not migrate toward
CXCL1 (see online supplementary figure S2C). Additionally, while F4/80intLy6C IMCs did
respond to monocytic chemokines CCL2 and CCL7, F4/80lowLy6G IMCs did not (figure
2F, see online supplementary figure S2C). To corroborate these finding in vivo, we
performed intravenous infusions of CXCL1 (40 μg/kg body weight). Four hours after
CXCL1 injection, F4/80lowLy6G IMCs in the blood increased threefold and returned to
baseline at 24 h (figure 2G). Concomitantly, bone marrow F4/80lowLy6G IMCs decreased
sharply 4 h postinjection, and returned to baseline at 24 h (figure 2H). No changes in IMC
mobilisation were observed in control mice infused with phosphate-buffered saline (PBS)
alone (data not shown). Taken together, these results suggest that increased serum CXCL1,
largely due to increased adipose CXCL1 expression in obesity, may facilitate F4/80lowLy6G
IMC trafficking from bone marrow to infected gastric tissue. Furthermore, increased
F4/80lowLy6G IMC mobilisation was correlated with accelerated progression of
carcinogenesis in obese infected mice, suggesting involvement of this IMC subpopulation in
the disease process.
Obesity enhances gastric TH17 response in H felis-infected mice
Infiltrating immune cells, particularly T cells, are central to Helicobacter-induced gastritis
and cancer.221 Therefore, we began by characterising immune cell populations in gastric
tissue of our study mice. With addition of HFD, we saw a large influx of CD45 leukocytes
in the stomach of H felis-infected mice, compared with lean infected controls (figure 3A). In
H felis/HFD mice, there was a significant increase in CD4 T cells and a modest non-
significant decrease in CD8 T cells, compared with H felis/CD mice (figure 3B). CD4 IHC
confirmed that CD4 cells were heavily recruited during infection, particularly with HFD.
With H felis infection, CD4 cells were scattered throughout the epithelium, though they
primarily aggregated at the base or top of glands, and were rarely found within lymphoid
aggregates (figure 3C).
Cells expressing the CD4 surface antigen include the TH cell populations TH1, TH2 and
TH17.2330 Gastric tissues were screened for changes in expression of cytokines classically
associated with these TH cell populations (figure 3D). We observed increased IL-17A,
suggesting a heightened TH17 response (figure 3D). Interferon (IFN)γ and IL-4 expression
were only modestly elevated upon administration of HFD to infected mice (figure 3D),
suggesting that the TH1 and TH2 responses are minimally involved. Elevated gastric IL-17A
protein was confirmed by ELISA and IHC (see online supplementary figure S3A,B).
Furthermore, gastric GM-CSF expression was increased in H felis/HFD mice compared with
H felis/CD mice (figure 3E), which has been strongly linked to TH17 pathogenesis.24
Expression of other TH17-associated cytokines (IL-17F, IL-21, IL-22, IL-6 and IL-1β) were
increased with H felis infection but unaffected by diet (see online supplementary figures
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S1C,S3C). IL-11 has been shown to induce gastric tumours in genetic models,35 however,
we observed no change in gastric IL-11 expression (see online supplementary figure S1C).
To assess changes in TH17 recruitment we measured gastric expression of CCL20, a
chemokine that mediates TH17 cell trafficking.36 CCL20 mRNA expression was unaffected
by diet in infected mice, so it is unlikely that HFD influences TH17 recruitment (figure 3F).
Next we investigated changes in TH17 differentiation. Cytokines involved in TH17
differentiation and maintenance, including IL-6, IL-1β and IL-21, were not elevated in
gastric tissue of H felis/HFD mice compared with H felis/chow mice (see online
supplementary figure S3C). Therefore, we speculate that circulating TH17-differentiation
factors, including IL-6, are responsible for enhanced TH17 development. In vitro studies
have shown that IL-6 and TGF-β together are sufficient to generate IL-17A-producing TH17
cells from isolated naïve T cells.230 Interestingly, using this in vitro assay, we found that
leptin increased the percentage of IL-17A-expressing T cells in the presence of IL-6 and
TGF-β, but had no significant effect alone (figure 3G). These data suggest that together
elevated serum IL-6 and leptin in obese infected mice contributed to a pathogenic TH17
response in the stomach.
H felis infection increases adipose inflammation in obese mice
Next, we investigated the effect of H felis infection on adipose inflammation. In obese mice,
H felis infection significantly increased visceral adipose IL-6, leptin, Saa3 and iNOS
expression (figure 4A). These factors have proinflammatory activity and are elevated in
adipose tissue of obese humans.3928 Not all proinflammatory cytokines associated with
obesity were upregulated by H felis infection, as TNF-α and IL-1β expression were similar
in obese and lean infected groups (see online supplementary figure S4A). We also observed
a significant increase of two classical adipose-derived inflammatory factors, PAI-1 and
resistin2437 in the serum of H felis/HFD mice compared with uninfected/HFD controls
(figure 4B). Adipose tissue contains many cell populations in addition to adipocytes,
including resident immune cells, which are found in the adipose stromal vascular fraction
(SVF). Thus, adipose SVF density can provide a measure of immune cell accumulation.12
Indeed, adipose SVF cells were increased in H felis/HFD mice was significantly increased
compared with uninfected/HFD mice (figure 4C). This finding was confirmed by calculation
of nuclei density in visceral adipose tissue H&E staining (see online supplementary figure
S4B). Interestingly, H felis infection did not induce adipose inflammation in lean mice for
any parameter tested (figure 4, see online supplementary figure S4). Stromal cell
accumulation has been reported to correlate with both adipocyte size and overall body
adiposity,68 but we observed no difference in these parameters between HFD groups (figure
4C, see online supplementary figures S1B,S4B).
It is now appreciated that multiple immune cell types traffic to adipose tissue in obesity,
including macrophages and T cells.6 Accordingly, we measured expression of immune cell
markers in visceral adipose tissue and found that H felis infection specifically upregulated
F4/80, a macrophage marker (figure 4D). There was no change in B cell, T cell or natural
killer cell markers (figure 4D). Confirming this finding, we observed increased F4/80 cells
in visceral adipose tissue by IHC (figure 4E). These data suggest that macrophages are the
primary immune population affected by H felis infection in adipose tissue of obese mice. In
sum, H felis infection increased macrophages in adipose tissue of obese mice, but not lean
mice, which likely contributed to elevated serum proinflammatory cytokines IL-6 and leptin.
H felis infection augments monocyte/macrophage chemotaxis to adipose tissue
Enhanced macrophage accumulation can occur through chemokine-based recruitment or
proliferation of existing myeloid cells.38 To examine cell proliferation, we performed Ki67
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IHC on visceral adipose tissue and found no difference in Ki67 cells among study groups
(figure 5A). To further investigate proliferation, BrdU cell populations were quantified by
flow cytometry from whole visceral adipose tissue and SVF of BrdU-injected HFD study
groups. Surprisingly, we saw a significant decrease in the percentage of total BrdU adipose
tissue cells and CD11bBrdU myeloid cells in H felis/HFD mice compared with uninfected/
HFD mice (figure 5B), excluding proliferation as a major contributor to myeloid cell
accumulation in H felis/HFD adipose tissue.
To assess the role of adipose-derived chemokine recruitment of myeloid cells, we measured
adipose tissue production of CCL- 2, 3, 4, 5, 7, 8 and CXCL14. Adipose chemokine
production plays an important role in modulating obesity-associated inflammation.68
Disruption of monocytic chemokine signalling pathways in obese mice can decrease adipose
tissue macrophage infiltration and improve the adipose tissue inflammatory profile.39 Of the
chemokines tested, only CCL7 was differentially expressed between infected and uninfected
obese mice (figure 5C). Serum CCL7 was also significantly elevated in infected obese mice
compared with uninfected controls (figure 5D). It is likely that elevated serum CCL7 protein
in the H felis/HFD mice is primarily a result of adipose-derived CCL7 production, as gastric
tissue CCL7 mRNA was only slightly increased (see online supplementary figure S4C).
Blood IMCs were not elevated after intravenous CCL7 injection, suggesting that, unlike
CXCL1, CCL7 does not affect IMC mobilisation from the bone marrow to the blood (data
not shown).
Last, we investigated if gastric-derived factors, including IL-17A and GM-CSF, were able to
modulate adipose CCL7 production in obese mice. Although serum IL-17A concentrations
were below our assay sensitivity for many mice, it could be detected in some infected mice.
Serum GM-CSF levels in the four study groups showed a similar trend as seen in gastric
tissue GM-CSF levels, with highest levels found in the H felis/HFD group (see online
supplementary figure S4D). To assess modulation of CCL7 production, we stimulated
visceral adipose SVF cells isolated from uninfected obese with recombinant IL-17A and/or
GM-CSF for 72 h. Stimulation with IL-17A or GM-CSF separately increased CCL7
production 1.5-fold. Stimulation with IL-17A and GM-CSF together increased CCL7
production 2–2.5-fold, in a dose-dependent manner (figure 5F). These data suggest that
IL-17A and GM-CSF produced during H felis infection may be able to stimulate CCL7
production in obese adipose tissue, increasing macrophage accumulation and subsequently,
raising systemic inflammation.
DISCUSSION
In obese, compared with lean H felis-infected mice, we observed severe gastritis and
accelerated gastric carcinogenesis. These mice developed an enhanced protumorigenic
gastric microenvironment, characterised by increased IMC infiltration and elevated TH17
response. Gastric epithelial STAT3 activity was also increased in these mice, in conjunction
with heightened expression of prosurvival genes. At the same time, H felis infection
amplified adipose macrophage accumulation and proinflammatory cytokine production in
visceral adipose tissue of obese, but not lean, mice.
Our results suggest that diet-induced obesity influences gastric carcinogenesis during H felis
infection through a proinflammatory positive feedback signalling loop between adipose and
gastric tissues (figure 6). When adipose tissue becomes inflamed, it appears to become
sensitised to circulating H felis-associated proinflammatory signals. The resultant increase in
adipose-derived serum factors modulates gastric IMC mobilisation (via CXCL1) and TH17
response (via IL-6 and leptin), both of which have been associated with a protumorigenic
gastric microenvironment.262730 Consequently, a positive feedback inflammatory signalling
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loop is established between adipose and gastric tissues during obesity and H felis infection,
accelerating the process of gastric carcinogenesis. It is important to note that, for this self-
propagating signal to occur, the adipose tissue must already be inflamed, thereby `priming'
adipose tissue to respond to H felis-associated cytokine signalling.
Based on our results, it is likely that obesity accelerates progression of gastric
carcinogenesis during H felis infection, in part, through induction of STAT3 signalling. In
addition to STAT3-mediated promotion of cellular transformation in epithelial cells,3140
STAT3 is also a master regulator of inflammatory gene expression and contributes to a
cancer-promoting microenvironment.41 In obese infected mice, there was a dramatic
increase in serum IL-6 and leptin levels which, at least partly, contributed to gastric STAT3
activation, despite unchanged gastric IL-6 and IL-11 expression. Specific STAT3 activation
in the gastric epithelial cells of H felis/HFD mice likely also involved localised
inflammatory signalling factors, such as other interleukins and IFNs, known to activate
STAT3.42 Consistent with our findings, IL-6 has been shown to enhance tumour
progression,43 and high serum IL-6 levels are negatively correlated with gastric cancer
survival.35 Additionally, disruption of leptin signalling has been shown to reduce STAT3-
mediated gastric hyperplasia.44
Furthermore, we demonstrate that inflamed gastric and adipose tissues used CXCL1 to
elevate circulating IMCs. CXCL1 is a known chemotactic factor for mature neutrophils,45
and studies with obese mice lacking the CXCL1 receptor CXCR2 have reduced neutrophil
recruitment to adipose tissue.34 Furthermore, CXCL1 has also been shown to be upregulated
in murine gastric preneoplasia,3345 suggesting a role for this chemokine in both gastric
cancer and obesity. Here, we show that intravenous CXCL1 infusion leads to rapid, transient
mobilisation of CD11bLy6G IMCs. Further studies are required to identify the specific
activity of these IMCs, which have also been labelled polymorphonuclear MDSCs (PMN-
MDSCs)46 in gastric tissue of H felis-infected mice. Given our results, we suspect this IMC
subset plays a pathogenic role in gastric carcinogenesis.
We also observed an increase in the gastric TH17 response, characterised by upregulated
IL-17A and GM-CSF, upon addition of HFD in infected mice. Consistent with our findings,
it has been recently suggested that IL-17A can foster gastrointestinal tumour development.25
Furthermore, the presence of IL-17A-producing cells in patients is associated with a worse
prognosis for both gastric47 and colorectal cancers.48 Our data provides additional evidence
that IL-17A is involved in inflammation-based gastrointestinal carcinogenesis and,
furthermore, is sensitive to obesity-derived proinflammatory factors. We also demonstrate
that IL-6 and leptin together can contribute to the initiation of a TH17 transcriptional profile
in naive T cells, and speculate that leptin may be involved in TH17 differentiation and
maintenance during obesity. We observed a marked and synergistic increase in GM-CSF
expression in gastric tissue of obese, but not lean, infected mice. It has recently been
proposed that GM-CSF production by TH17 cells is a critical mediator of TH17
pathogenicity.49 Independent of the TH17 response, GM-CSF has also been associated with
accumulation of suppressive IMCs in multiple tumour models.1617 Future studies are needed
to clarify the effect of leptin on GM-CSF production in TH17 cells and on TH17
pathogenicity.
Unexpectedly, H felis infection increased adipose CCL7 chemokine production, macrophage
recruitment and adipose inflammation in obese mice. H felis infection did not alter
inflammatory status of lean adipose tissue; thus, it appears that an already expanded,
inflamed visceral adipose tissue is necessary for this process. It has been shown that
knockout of CCL7 receptor, CCR2, reduces adipose inflammation, although the role of
CCL7 in monocyte/macrophage recruitment to adipose tissue during obesity is still largely
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unknown.39 Intriguingly, CCL7 has previously been shown to increase after stimulation
with IL-17A.23 In support of this finding, we show that IL-17A and/or GM-CSF, both of
which were highly expressed in the H felis-infected stomach, are able to stimulate CCL7
production from obese adipose tissue cells in vitro. Adipose-derived CCL7 may also have an
adverse effect in the stomach, as high gastric CCL7 levels in gastric cancer patients has been
correlated with more advanced tumour progression.50
Dysregulation of the gut microbiome by HFD and H felis infection may also have increased
systemic inflammation and contributed to the adipose or gastric pathology observed in H
felis/HFD mice. Mice on HFD show altered gut microbiome composition and increased
endotoxemia compared with mice on control diet.51 It would therefore be interesting to
investigate if H felis infection and HFD together can further alter the gut microbiome,
providing an additional mechanism through which H felis and HFD work synergistically to
accelerate gastric carcinogenesis.
In summary, we have identified a proinflammatory signalling mechanism between gastric
and adipose tissues, coordinated by Helicobacter infection and obesity. Over time, this
proinflammatory milieu upregulated local and systemic proinflammatory factors and
accelerated the process of gastric carcinogenesis. Obese inflamed adipose tissue, compared
with lean adipose tissue, appears to have the unique ability to amplify H felis-associated
inflammation via a complex signalling loop involving IMC accumulation in blood and
gastric tissue, TH17 response in gastric tissue and macrophage infiltration in adipose tissue.
This signalling loop is only propagated in the presence of inflamed adipose tissue, as lean
adipose tissue is not sensitised to respond to H felis-associated inflammation.
Epidemiological studies have demonstrated that H pylori infection and obesity are
independent risk factors for gastric cancer,45 although these risk factors may not coincide as
often, given that obesity is not as common in countries where H pylori infection is
endemic.5253 Additionally, body mass index of individuals infected with H pylori increases
after eradication,54 suggesting a possible inverse relationship between H pylori infection and
obesity. Nevertheless, our results clearly demonstrate that H felis infection and HFD have a
synergistic effect on gastric carcinogenesis, and may also provide insight into the
mechanisms through which obesity increases risk of other solid cancers. It is possible that
obesity can accelerate carcinogenesis in other organs through a similar immunomodulatory
mechanism.
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Significance of this study
What is already known on this subject?
▶ Obesity causes a state of systemic low-grade inflammation and is correlated
with increased risk of certain cancers, including gastric cancer.
▶ Adipose-derived factors can promote tumour cell growth in vivo and in vitro.
▶ In humans, serum IL-6 concentration is elevated in obese individuals and is
positively correlated with gastric cancer development and progression.
What are the new findings?
▶ Diet-induced obesity accelerated Helicobacter felis-induced gastric
inflammation and carcinogenesis.
▶ Obesity promoted a protumorigenic gastric microenvironment and induced
gastric STAT3 signalling.
▶ Obesity enhanced IMC recruitment and TH17-associated responses in the
stomachs of Helicobacter-infected mice.
▶ High-fat diet plus Helicobacter felis infection significantly increased serum
IL-6 and leptin concentrations, compared with obesity or infection alone.
▶ H felis infection increased macrophage accumulation, as well as CCL7 and
leptin expression, in obese, but not lean, visceral adipose tissue.
How might it impact on clinical practice in the foreseeable future?
▶ Obesity and associated adipose inflammation significantly enhanced H felis-
driven gastric carcinogenesis. Modulation of adipose inflammation may
improve gastric cancer risk in obese patients. Obesity prevention measures,
especially in children, will also play an important role in addressing this
cancer risk.
▶ Serum IL-6 was the most significantly elevated cytokine in obese infected
mice. Thus, serum IL-6 levels may be a useful indicator of obese individuals
at higher risk of developing gastric cancer.
▶ Helicobacter infection augmented adipose tissue macrophage infiltration and
inflammation in obese mice. Eradication of gastric Helicobacter species
infection may improve obesity-associated adipose inflammation and obesity-
associated pathologies.
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Figure 1.
(A) Average body mass (g) of study mice from 1–68 weeks. (B) Representative gross
images of stomach, 15 months postinfection (PI). Inflamed/dysplastic region circled by blue
dotted line. (C) Percent corpus inflamed/dysplastic, calculated from gross gastric images.
(D) Representative images of gastric corpus H&E histology, 15 months PI. scale bars=100
μm. (E) Gastric histopathological scores at 10 and 15 months PI. (F) Representative images
of phosphorylated (p)STAT3 immunohistochemistry in gastric corpus. Scale bar=50 μm.
(G) mRNA quantification of Mcl-1, Bcl-XL, c-Myc, survivin, miR21 and miR181b in
gastric corpus by qRT-PCR. (H) Serum IL-6 and leptin protein quantification by milliplex.
*p<0.05, #p<0.01, §p<0.001.
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Figure 2.
(A and B) Cells isolated from stomach, blood and spleen, stained with anti-CD45, CD11b,
Gr1, F4/80, Ly6C and Ly6G antibodies, analysed by flow cytometry. (A) Total Gr1CD11b
immature myeloid cell (IMC) quantification in gastric tissue, blood and spleen. (B)
F4/80lowLy6G IMC subset quantification in gastric tissue and blood. (C) Arg1 and iNOS
mRNA quantification from whole corpus gastric tissue by qRT-PCR. (D) Serum CXCL1
protein quantification by milliplex. (E) CXCL1 mRNA quantification in gastric corpus and
visceral adipose by qRT-PCR. p Values versus uninfected/CD. (F) Transwell migration
assay using fluorescence-activated cell sorting sorted CD11bGr1 IMCs from uninfected/CD
whole bone marrow. Migrated cells stained with anti-F4/80, anti-Ly6C and anti-Ly6G
antibodies, quantified with counting beads by flow cytometry; n=3–4 wells/condition, one
representative shown of three independent experiments, p values versus uninfected/CD. (G
and H) Intravenous injection of recombinant murine CXCL1 (40 μg/kg body mass) or sterile
PBS. Blood (G) and bone marrow (H) cells stained with anti-CD45, CD11b, Gr1, F4/80,
Ly6C and Ly6G antibodies, quantified by flow cytometry; n=3–4 mice/condition.
*p<0.05, #p<0.01, §p<0.001. CXCL, Chemokine C-X-C motif ligand.
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Figure 3.
(A) Gastric leukocytes isolated from whole gastric tissue, stained with anti-CD45, CD3,
CD4 and CD8 antibodies, quantified by flow cytometry. CD45 gastric leukocytes
normalised to total isolated cells. (B) Representative plots for T cell CD4 and CD8
expression, pregated for CD45CD3 cells. Absolute CD4 and CD8 T cells, normalised to 100
CD45 non-immune cells. Proportional gastric CD4 T cells and CD8 T cells, normalised to
total T cells (CD45CD3). (C) Representative images of CD4 immunohistochemistry in
gastric corpus. Scale bar=200 μm. (D–F) mRNA quantification of IL-4, and IFNγ and
IL-17A (D), GM-CSF (E) and CCL20 (F) in gastric corpus by qRT-PCR. (G) In vitro TH17
differentiation from isolated naive T cells, analysed by flow cytometry for intracellular
IL-17A. N=3–4 wells/condition, one representative of three independent experiments
shown. *p<0.05, #p<0.01, §p<0.001. CCL, C-C motif ligand; GM-CSF, granulocyte
macrophage-colony stimulating factor; IFN, interferon.
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Figure 4.
(A) mRNA quantification of iNOS, Saa3, leptin and IL-6 in visceral adipose by qRT-PCR.
(B) Serum PAI-1 and resistin protein quantification by milliplex. (C) Stromal vascular
section isolated from visceral adipose, quantified by haemocytometer, normalised to tissue
weight. (D) mRNA quantification of F4/80, CD4, CD2, NK1.1, CD20 and CD8α in visceral
adipose by qRT-PCR. (E) Representative images of F4/80 immunohistochemistry in visceral
adipose of high-fat diet groups. Minimum 10 representative fields quantified per mouse.
Scale bar=50 μm. *p<0.05, #p<0.01, §p<0.001.
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Figure 5.
(A) Representative images of Ki67 immunohistochemistry in visceral adipose of high-fat
diet (HFD) groups. Ki67 nuclei quantified, expressed as percentage of total adipocytes per
high-power field. Minimum 3 representative fields quantified per mouse. Scale bar=50 μm.
(B) BrdU cells in visceral adipose Stromal vascular section (SVF), analysed by flow
cytometry. Total SVF proliferation and total myeloid proliferation. Mice 2 months
postinfection, sacrificed 18 h post-BrdU injection. (C) mRNA quantification of CCL2, 3, 4,
5, 7, 8 and CXCL14 in visceral adipose by qRT-PCR. (D) Serum CCL7 protein
quantification by ELISA. (E) SVF cells isolated from uninfected/HFD visceral adipose,
stimulated with recombinant IL-17A and/or GM-CSF for 72 h. CCL7 in supernatant
quantified by ELISA. N=3–4 wells/condition, one representative of three independent
experiments shown. *p<0.05, #p<0.01, §p<0.001. CCL, C-C motif ligand; CXCL,
Chemokine C-X-C motif ligand; GM-CSF, granulocyte macrophage-colony stimulating
factor.
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Figure 6.
Schematic hypothesis of inflammatory cross-talk during Helicobacter felis infection and
diet-induced obesity. CXCL1 produced by adipose and gastric tissues (1) elevates
circulating bone marrow-derived immature myeloid cells (IMCs) (2). IMCs recruited to
gastric tissue by CXCL1 encounter TH17-associated cytokines, including GM-CSF, and
develop into myeloid-derived suppressor cells (3). Adipose CCL7 secretion increases IMC
recruitment to adipose (4), resulting in accumulation of adipose tissue macrophages (MΦ)
(5). Inflamed adipose produces IL-6 and leptin (6), promoting TH17 differentiation (7).
TH17-associated cytokines IL-17A and GM-CSF produced in the stomach signal to adipose
(8) to increase CCL7 production and amplify adipose inflammation. CCL, C-C motif ligand;
CXCL, Chemokine C-X-C motif ligand; GM-CSF, granulocyte macrophage-colony
stimulating factor.
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